Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developing a chiral toolbox for asymmetric catalytic reactions.

X Zhang1

  • 1Department of Chemistry, Pennsylvania State University, University Park 16802, USA. xumu@chem.psu.edu

Enantiomer
|February 15, 2000
PubMed
Summary

Chemists developed novel chiral ligands for transition metals, creating highly enantioselective catalysts. These catalysts enable efficient asymmetric transformations, advancing synthetic chemistry.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The gene for nucleoside diphosphate kinase functions as a mutator gene in Escherichia coli.

Journal of molecular biology·1995
Same author

Protective immunity induced by 67 K outer membrane protein of phase I Coxiella burnetii in mice and guinea pigs.

Acta virologica·1995
Same author

Using modified nucleotides to map the DNA determinants of the Tus-TerB complex, the protein-DNA interaction associated with termination of replication in Escherichia coli.

The Journal of biological chemistry·1995
Same author

Phospholipase A2 engineering. The roles of disulfide bonds in structure, conformational stability, and catalytic function.

Biochemistry·1995
Same author

Bicyclomycin and dihydrobicyclomycin inhibition kinetics of Escherichia coli rho-dependent transcription termination factor ATPase activity.

Archives of biochemistry and biophysics·1995
Same author

Laminin beta 2 chain and adhalin deficiency in the skeletal muscle of Walker-Warburg syndrome (cerebro-ocular dysplasia-muscular dystrophy).

Neurology·1995

Area of Science:

  • Organic Chemistry
  • Catalysis
  • Asymmetric Synthesis

Background:

  • Significant advancements in man-made catalysts for asymmetric transformations have been achieved.
  • Chiral ligands are crucial for developing highly enantioselective transition metal catalysts.
  • Restricting ligand conformational flexibility enhances catalyst performance.

Purpose of the Study:

  • To develop diverse chiral ligands for transition metal-catalyzed asymmetric reactions.
  • To address fundamental and practical challenges in asymmetric catalysis.
  • To synthesize novel ligands with rigid backbones for improved enantioselectivity.

Main Methods:

  • Design and synthesis of tridentate and bidentate phosphine ligands.
  • Development of novel chiral monophosphines.
  • Formation of transition metal complexes with synthesized ligands.
  • Application of catalysts in various asymmetric reactions.

Main Results:

  • Developed families of tridentate ligands for enantioselective hydrogenation of unfunctionalized substrates.
  • Synthesized new bidentate phosphine ligands with rigid structures for asymmetric catalysis.
  • Successfully applied novel chiral monophosphines and their metal complexes in asymmetric transformations.
  • Studied asymmetric hydrogenation of functionalized substrates, ketones, imines, and C-C bond forming reactions.

Conclusions:

  • Novel chiral ligands, including tridentate, bidentate phosphine, and monophosphine types, have been successfully developed.
  • These ligands, when complexed with transition metals, form highly enantioselective catalysts.
  • The developed catalysts are effective for a range of challenging asymmetric transformations, including hydrogenation and C-C bond formation.

Related Experiment Videos